Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide

Immunopharmacology

Volumn 43, Issue 1, 1999, Pages 59-64

  Dunzendorfer, Stefan ^a   Herold, Manfred ^a   Wiedermann, Christian J ^a  

^a NONE

Author keywords

Cytokines; Endothelium; Inflammation; Neutrophils; Thalidomide

Indexed keywords

CHEMOTAXIN; ENDOTOXIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; NEUTROPHIL; PRIORITY JOURNAL; UMBILICAL VEIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NEUTROPHILS; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033043493     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00041-7     Document Type: Article

References (17)

1. Burns M.J., Sellati T.J., Teng E.I., Furie M.B. Production of interleukin-8 (IL-8) by cultured endothelial cells in response to Borrelia burgdorferi occurs independently of secretion IL-1 and tumor necrosis factor alpha and is required for subsequent transendothelial migration of neutrophils. Infect. Immun. 65:1997;1217-1222.
2. DeBeaux A.C., Maingay J.P., Ross J.A., Fearon K.C.H., Carter D.C. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J. Interferon Cytokine Res. 15:1995;441-445.
3. Dunzendorfer S., Schratzberger P., Reinisch N., Kähler C.M., Wiedermann C.J. Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine- and endotoxin- activated endothelium. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;529-535.
4. Endo S., Inada K., Yamada Y., Takakuwa T., Nakae H., Kasai T., Koike S., Inoue Y., Niimi M., Wakabayashi G., Taniguchi S. Functional modification of vascular endothelial cells by cytokines during septic shock. Res. Commun. Mol. Pathol. Pharmacol. 94:1996;23-38.
5. Förster M., Neubert R. Lack of effects on fetal thymus and lymphocytes development in marmoset fetuses and newborns following treatment with thalidomide. Teratology. 51:1995;23A-24A.
6. Geitz H., Handt S., Zwingenberger K. Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology. 31:1996;213-221.
7. Gimbrone M.A., Obin M.S., Brock A.F., Luis E.A., Hass P.E., Hebert C.A., Yip Y.K., Leung D.W., Lowe D.G., Kohr W.J., Darbonne W.C., Bechtol K.B., Baker J.B. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science. 246:1989;1601-1603.
8. Glauser M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-736.
9. Goldblum S.E., Brann T.W., Ding X., Pugin J., Tobias P.S. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J. Clin. Invest. 93:1994;692-702.
10. Keenan R.J., Eiras G., Burckart G.J., Stuart R.S., Hardesty R.L., Vogelsang G., Griffith B.P., Zeevi A. Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. Transplantation. 52:1991;908-910.
11. Kishimoto T.K., Jutila M.A., Berg E.L., Butcher E.C. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science. 245:1989;1238-1241.
12. Kuijpers T.W., Hakkert B.C., Hart M.H.L. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J. Cell Biol. 117:1992;565-570.
13. Mantovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 6:1992;2591-2599.
14. Miyachi H., Azuma A., Hioli E., Iwasaki S., Kobayashi Y., Hashimoto Y. Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor alpha production. Biochem. Biophys. Res. Commun. 224:1996;426-430.
15. Wiedermann C.J., Niedermühlbichler M., Braunsteiner H. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J. Clin. Invest. 89:1992;1580-1586.
16. Wiedermann C.J., Schratzberger P., Kähler C.M. Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with β-endorphin. Brain Behav. Immunol. 8:1994;270-277.
17. Zwingenberger K., Wnendt S. Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations. J. Inflammation. 46:1996;177-211.